ABBOTT Archives

Continuous Glucose Monitoring Devices Overcoming Barriers in LMICs by EOS Implicium

Mind the Glucose Gap: Why CGM Still Struggles in Emerging Markets

13/01/2026by EOS Intelligence

The rising prevalence of diabetes in low- and middle-income countries (LMICs) underscores the need for advanced diabetes management solutions. Continuous glucose monitoring (CGM) systems are highly valuable but face limited...

The Future of Diabetes Care Key Innovations in the Continuous Glucose Monitoring by EOS Implicium

Reading Between the Glucose Lines as CGM Gets Smarter

06/01/2026by EOS Intelligence

Continuous glucose monitoring (CGM) has transformed the diabetes management landscape. In recent years, the CGM market has seen remarkable growth, becoming an integral part of diabetes care with the potential...

MDx Testing Moves Closer to Patients as Labs Lose Their Central Role

10/03/2025by EOS Intelligence

The COVID-19 pandemic brought innovation and investment to the in vitro diagnostics (IVD) market, opening new pathways to simplify and expand testing. The previously complicated and time-consuming molecular testing gradually...

Who We Are

Connect With Us

Work With EOS